70 related articles for article (PubMed ID: 9544675)
21. FDG PET and dual-head gamma camera positron coincidence detection imaging of suspected malignancies and brain disorders.
Delbeke D; Patton JA; Martin WH; Sandler MP
J Nucl Med; 1999 Jan; 40(1):110-7. PubMed ID: 9935066
[TBL] [Abstract][Full Text] [Related]
22. Fluorine-18 FDG dual-head gamma camera coincidence imaging of radiation pneumonitis.
Lin P; Delaney G; Chu J; Kiat H; Pocock N
Clin Nucl Med; 2000 Nov; 25(11):866-9. PubMed ID: 11079581
[TBL] [Abstract][Full Text] [Related]
23. Scanning with 18F-FDG-PET/CT for detection of pelvic nodal involvement in inguinal node-positive penile carcinoma.
Graafland NM; Leijte JA; Valdés Olmos RA; Hoefnagel CA; Teertstra HJ; Horenblas S
Eur Urol; 2009 Aug; 56(2):339-45. PubMed ID: 19477581
[TBL] [Abstract][Full Text] [Related]
24. A new imaging technique for colorectal cancer: positron emission tomography.
Flamen P; Van Cutsem E; Mortelmans L
Semin Oncol; 2000 Oct; 27(5 Suppl 10):22-9. PubMed ID: 11049029
[No Abstract] [Full Text] [Related]
25. Diagnostic value of PET/CT is similar to that of conventional MRI and even better for detecting small peritoneal implants in patients with recurrent ovarian cancer.
Sanli Y; Turkmen C; Bakir B; Iyibozkurt C; Ozel S; Has D; Yilmaz E; Topuz S; Yavuz E; Unal SN; Mudun A
Nucl Med Commun; 2012 May; 33(5):509-15. PubMed ID: 22357440
[TBL] [Abstract][Full Text] [Related]
26. Impact of (18) F-fluorodeoxyglucose (FDG)-positron-emission tomography/computed tomography (PET/CT) on management of patients with carcinoma invading bladder muscle.
Mertens LS; Fioole-Bruining A; Vegt E; Vogel WV; van Rhijn BW; Horenblas S
BJU Int; 2013 Oct; 112(6):729-34. PubMed ID: 23790129
[TBL] [Abstract][Full Text] [Related]
27. Carcinoembryonic antigen (CEA) scan in the diagnosis of recurrent colorectal carcinoma in a patient with increasing CEA levels and inconclusive computed tomographic findings.
Ghesani M; Belgraier A; Hasni S
Clin Nucl Med; 2003 Jul; 28(7):608-9. PubMed ID: 12819425
[No Abstract] [Full Text] [Related]
28. [Usefulness of 18F-fluorodeoxyglucose positron emission tomography/computerized tomography in diagnosis and treatment of pelvic recurrence of bladder cancer after radical cystectomy: a case report].
Inoue M; Numao N; Ito M; Masuda H; Kobayashi T; Kawakami S; Kihara K
Hinyokika Kiyo; 2007 Sep; 53(9):653-6. PubMed ID: 17933144
[TBL] [Abstract][Full Text] [Related]
29. RadioimmunoPET: detection of colorectal carcinoma with positron-emitting copper-64-labeled monoclonal antibody.
Philpott GW; Schwarz SW; Anderson CJ; Dehdashti F; Connett JM; Zinn KR; Meares CF; Cutler PD; Welch MJ; Siegel BA
J Nucl Med; 1995 Oct; 36(10):1818-24. PubMed ID: 7562049
[TBL] [Abstract][Full Text] [Related]
30. Coincidence imaging using 2 dual-head gamma-camera systems, with and without attenuation correction.
Even-Sapir E; Yuzefovich B; Miller E; Bouhnik JP; Zak O; Lerman H; Lievshitz G; Levin C
J Nucl Med Technol; 2004 Dec; 32(4):190-7. PubMed ID: 15576340
[TBL] [Abstract][Full Text] [Related]
31. F-18-FDG positron imaging in oncological patients: gamma camera coincidence detection versus dedicated PET.
Zimny M; Kaiser HJ; Cremerius U; Sabri O; Schreckenberger M; Reinartz P; Büll U
Nuklearmedizin; 1999; 38(4):108-14. PubMed ID: 10392375
[TBL] [Abstract][Full Text] [Related]
32. [Usefulness of scintigraphy images with 111In-CYT-103 in the diagnosis of colonic and rectal recurrence].
García-Fernández R; Luna-Pérez P; Hernández-Hernández DM; Iwasaki-Otake L; Pichardo-Romero P; Rodríguez-Ramirez S
Gac Med Mex; 2002; 138(2):139-44. PubMed ID: 12001423
[TBL] [Abstract][Full Text] [Related]
33. 18FDG PET/CT findings in the unusual urachal adenocarcinoma.
Guimarães MD; Bitencourt AG; Lima EN; Marchiori E
Clin Nucl Med; 2014 Sep; 39(9):831-4. PubMed ID: 24566402
[TBL] [Abstract][Full Text] [Related]
34. 18F-FDG PET in evaluating patients treated for metastatic colorectal cancer: can we predict prognosis?
Metser U
J Nucl Med; 2004 Sep; 45(9):1428-30. PubMed ID: 15347706
[No Abstract] [Full Text] [Related]
35. Immunoscintigraphy in colorectal cancer: surgeon's perspective.
Doerr RJ; Abdel-Nabi H
Int J Biol Markers; 1993; 8(2):73-6. PubMed ID: 8366298
[TBL] [Abstract][Full Text] [Related]
36. Patterns of lymphatic metastases at recurrence of prostate cancer: CT findings.
Spencer JA; Golding SJ
Clin Radiol; 1994 Jun; 49(6):404-7. PubMed ID: 8045065
[TBL] [Abstract][Full Text] [Related]
37. F-18 FDG PET imaging of urinary bladder oat cell carcinoma with widespread osseous metastases.
Iagaru A; Gamie S; Segall G
Clin Nucl Med; 2006 Aug; 31(8):476-8. PubMed ID: 16855436
[No Abstract] [Full Text] [Related]
38. Calyceal rupture secondary to ureteric obstruction by recurrent colorectal carcinoma.
Heffernan EJ; Skehan SJ
Clin Nucl Med; 2007 Mar; 32(3):199-200. PubMed ID: 17314594
[No Abstract] [Full Text] [Related]
39. Decision analysis for the cost-effective management of recurrent colorectal cancer.
Park KC; Schwimmer J; Gambhir SS
Ann Surg; 2002 Feb; 235(2):309-10; author reply 310. PubMed ID: 11807375
[No Abstract] [Full Text] [Related]
40. Nuclear medicine: the road to smart medicine and surgery.
Wagner HN
J Nucl Med; 1998 Aug; 39(8):13N-17N, 19N, 23N-24N passim. PubMed ID: 9708496
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
